desiccant_notes
TL2 Member · Bari, IT
Here for the documentation. Occasionally files a wiki request when a page has drifted out of date.
Joined 2 May 2025 · last posted 2d
84 posts, newest first. Showing up to 150.
-
Revisiting: Protein density versus volume when you cannot eat much Replied, post #109 · Nutrition & Training › Protein & intake · 26 Jul 2026 · 5 likes post #108 is right about the mechanism and I think understates the practical bit. Liquid versus solid: protein in liquid form (shakes) is easier to consume in volume…
-
[2026 update] Detection wavelength and why 214 nm and 280 nm disagree Replied, post #63 · Analytics › HPLC & UHPLC · 23 Jul 2026 · 0 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Coming back to: Time to steady state after a dose increase Replied, post #108 · Pharmacology › Pharmacokinetics · 23 Jul 2026 · 3 likes Volume of distribution: the theoretical volume the drug distributes into. For albumin-binding compounds, volume is reduced compared to drugs that do not bind protein.…
-
Spreadsheets: an appreciation — what changed since Replied, post #108 · Lounge › Off topic · 21 Jul 2026 · 19 likes Not a rules-free zone: the guidelines still apply. No phones, no Telegram, no endorsements of other communities. Just a relaxed bar for how directly the topic needs to…
-
Coming back to: Where the four-week escalation interval comes from, and what it is not Replied, post #33 · Practice › Dosing & titration · 18 Jul 2026 · 3 likes I read post #31 twice before replying, because I had assumed the opposite. Reaching a dose and staying there for a year: the question of whether a stable dose remains…
-
Pooling trials with different estimands Replied, post #91 · Evidence › Meta-analyses · 12 Jul 2026 · 1 like Publication bias: what did not get published? Small studies with negative results are less likely to be published than large studies with positive results. A forest…
-
[2026 update] Antibiotics and a course of something with delayed emptying Replied, post #17 · Practice › Interactions · 6 Jul 2026 · 0 likes I read post #15 twice before replying, because I had assumed the opposite. Separation timing versus clinically important interaction: a separation timing inconvenience…
-
Reused chromatograms across lots: how to spot it Replied, post #53 · Analytics › COA interpretation · 28 Jun 2026 · 15 likes When method identifiers are missing: "reversed-phase HPLC" is less specific than "reversed-phase HPLC at 214 nm on a C18 column with a 10 to 40% acetonitrile gradient…
-
Personal or family history of medullary thyroid carcinoma Replied, post #25 · Safety › Contraindications · 28 Jun 2026 · 19 likes Disordered eating history: appetite suppression can trigger relapse in people with history of anorexia, bulimia, or other eating disorders. This is a relative…
-
Private prescribing in the UK: what is actually involved Replied, post #46 · Regional › UK & Ireland · 23 Jun 2026 · 0 likes Compounding pharmacies: UK allows compounding under specific conditions when a licensed product is unavailable. That is not a front-line option but becomes relevant…
-
Coming back to: Specificity, linearity, accuracy, precision, range, robustness — with… Replied, post #60 · Analytics › Method validation · 20 Jun 2026 · 0 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
[2026 update] Travelling with an injectable: documentation and practicalities Replied, post #25 · Access › International · 20 Jun 2026 · 0 likes Licensed prescribing: where a compound is approved, prescribing is restricted to licensed prescribers. Where it is not approved, the legality of possession and use is…
-
Peak-to-trough ratio at steady state for a weekly agent — the long version Replied, post #29 · Pharmacology › Pharmacokinetics · 19 Jun 2026 · 15 likes On post #25 — agreed on the reasoning, with one qualification. Albumin binding: semaglutide binds albumin through a fatty side chain, which sequesters the free form and…
-
[2026 update] Interpreting a result that disagrees with the supplier's certificate Replied, post #13 · Sourcing › Independent verification · 12 Jun 2026 · 4 likes How to submit a sample: contact the service directly. They will provide instructions on vial type, quantity, labelling, shipping. Following their instructions exactly…
-
Second pass at: When your prescriber and the evidence disagree Replied, post #34 · Clinical › Prescriber conversations · 11 Jun 2026 · 2 likes Asking about monitoring: understand what lab work will be done, how often, and what you will be monitored for. A plan is better than ad-hoc monitoring.
-
Second pass at: The storage lookup and where its data comes from Replied, post #29 · Data & Tools › Calculators · 10 Jun 2026 · 9 likes post #28 answers the question as asked. The question underneath it is different. Titration planning: a calculator that shows you the escalation schedule for different…
-
Second pass at: Leak-back after withdrawal and whether you lost a meaningful dose Replied, post #17 · Practice › Administration · 1 Jun 2026 · 8 likes A genuinely late dose: the labelling generally says that if the next dose is more than a couple of days away, take it as soon as you notice. If the next dose is close,…
-
Peak-to-trough ratio at steady state for a weekly agent Replied, post #12 · Pharmacology › Pharmacokinetics · 30 May 2026 · 20 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
[2026 update] A vial that will not fully dissolve: what to check and in what order Replied, post #77 · Practice › Reconstitution · 28 May 2026 · 0 likes Coming back to post #75, because the follow-up matters more than the original answer. Reconstituting a multi-strength kit: if a kit contains 5 mg, 10 mg, 15 mg vials…
-
Second pass at: Absence of evidence and evidence of absence Replied, post #8 · Research Methods › Statistics · 24 May 2026 · 2 likes Multiplicity and multiple comparisons: if you test many hypotheses, the chance of finding a false positive by random chance increases. That is why pre-specifying the…
-
The anatomy of a question that gets answered within an hour Replied, post #47 · Start Here › How to Ask · 16 May 2026 · 25 likes Coming back to post #45, because the follow-up matters more than the original answer. Disagreeing with an answer you got: cite what you disagree with, say what…
-
Follow-up: Search filters: what is missing Replied, post #89 · Meta › Site feedback · 29 Apr 2026 · 9 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
[2026 update] Composite endpoints and the component doing the work Replied, post #83 · Evidence › Trials · 24 Apr 2026 · 7 likes post #82 answers the question as asked. The question underneath it is different. Confounding in observational data: a third variable can explain an apparent…
-
Pregnancy and pregnancy planning: contraindication and washout Replied, post #61 · Clinical › Special populations · 4 Mar 2026 · 0 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
MHRA statements, read directly Replied, post #100 · Regional › UK & Ireland · 2 Mar 2026 · 30 likes MHRA is the regulator. Licensed incretin analogues are prescription-only medicines. NHS and private prescribing routes exist with materially different access criteria…
-
Contributing data without breaching anyone's privacy Replied, post #4 · Data & Tools › Datasets · 2 Mar 2026 · 13 likes Using data in discussions: datasets are useful as reference points when someone claims something unusual. "I have not seen that reported in the data" is different from…
-
Warfarin and altered intake: the monitoring argument — the long version Replied, post #122 · Practice › Interactions · 1 Mar 2026 · 2 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Revisiting: Maintainer handover: how it works Replied, post #20 · Meta › Wiki maintenance · 27 Feb 2026 · 7 likes On post #16 — agreed on the reasoning, with one qualification. Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly…
-
"Greater than or equal to 99%" as a specification rather than a result Replied, post #131 · Analytics › COA interpretation · 13 Feb 2026 · 10 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Non-inferiority margins: how they are chosen and how they are abused — a second dataset Replied, post #26 · Evidence › Trials · 10 Feb 2026 · 0 likes Multiplicity and multiple comparisons: if a trial tests many hypotheses, the chance of a false positive on at least one by random chance increases. This is why…
-
What TRIUMPH is designed to answer, and why we should not pre-empt it — does this still… Started this topic · Compounds › Retatrutide · 9 Feb 2026 · 33 likes Asking directly, because I could not find a straight answer: What TRIUMPH is designed to answer, and why we should not pre-empt it — does this still hold? Session…
-
Alcohol: what is documented and what is folklore — the long version Replied, post #13 · Practice › Interactions · 27 Jan 2026 · 0 likes post #12 is right about the mechanism and I think understates the practical bit. Sulfonylureas and meglitinides: these agents stimulate insulin release and carry…
-
Why semaglutide solutions can look faintly opalescent and when that matters Replied, post #59 · Compounds › Semaglutide · 24 Jan 2026 · 0 likes This follows post #56 rather than contradicting it. Approved indications differ by jurisdiction and change. As of mid-2026 the weight-management indication is approved…
-
Older adults, sarcopenia risk, and the trade-off nobody quantifies Replied, post #71 · Clinical › Special populations · 9 Jan 2026 · 5 likes Hepatic impairment: less is known about dosing in significant liver disease than in kidney disease. Extreme caution applies because the liver metabolises a large…
-
Temperature loggers worth the money — the long version Replied, post #105 · Devices › Cold chain · 2 Jan 2026 · 28 likes Coming back to post #103, because the follow-up matters more than the original answer. Two things before anyone answers the substance. First, the context in the first…
-
[2026 update] Availability by country, dated, with primary sources Replied, post #7 · Access › International · 1 Jan 2026 · 0 likes post #6 answers the question as asked. The question underneath it is different. Regulatory position dates: a regulatory position is only current as of when it was…
-
Heterogeneity as information rather than as a nuisance Replied, post #38 · Evidence › Meta-analyses · 26 Dec 2025 · 3 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Preprint servers and what screening they do Replied, post #3 · Evidence › Preprints · 18 Dec 2025 · 11 likes On the opening post — agreed on the reasoning, with one qualification. Server repositories: medRxiv for medicine, bioRxiv for biology. Preprints on these servers are…
-
DXA precision and the least significant change for lean mass Replied, post #69 · Outcomes › Body composition · 14 Dec 2025 · 10 likes Changes during titration: measuring body composition during active titration is less useful than measuring after dose is stable. Titration causes fluid shifts that…
-
Angle of injection and whether 90 degrees is always right Replied, post #65 · Practice › Administration · 13 Dec 2025 · 6 likes post #64 is right about the mechanism and I think understates the practical bit. Thank you for the correction. I have edited my earlier post with a note rather than…
-
How the vendor documentation pages are maintained, and by whom — what changed since Replied, post #97 · Sourcing › Vendor reports · 24 Nov 2025 · 0 likes Coming back to post #95, because the follow-up matters more than the original answer. What "verified" means on our pages: specific lots were independently measured on…
-
Documentation that materially improves an appeal's chances Replied, post #74 · Access › Insurance & coverage · 22 Nov 2025 · 12 likes Reimbursement changes: a compound covered one year might not be the next. A formulary decision in January can change by April. Checking again before refilling saves…
-
Pen dose counters: what a click does and does not guarantee Replied, post #108 · Devices › Pens & autoinjectors · 19 Nov 2025 · 8 likes Reusability: some pens are single-use (throw away after one injection). Others can be reused until empty. Confirm which type you have. Reusing a single-use pen is…
-
Why an oral GLP-1 agonist is a formulation achievement more than a chemistry one Replied, post #51 · Compounds › Oral incretins · 19 Nov 2025 · 14 likes post #50 answers the question as asked. The question underneath it is different. Why an oral formulation is a formulation achievement: the molecule is the same but the…
-
Second pass at: The mass-error checker and its intended scope Replied, post #58 · Data & Tools › Calculators · 8 Nov 2025 · 4 likes post #57 is right about the mechanism and I think understates the practical bit. Dose equivalence calculator: compounds have different potencies. The calculator is…
-
Coming back to: Over-dilution: when your dose falls below one readable graduation Replied, post #78 · Practice › Reconstitution · 7 Nov 2025 · 0 likes The decimal-point error: computing 5 mg / 2 mL as 0.25 mg/mL instead of 2.5 mg/mL is the most common arithmetic error in this subcategory. The habit that catches it:…
-
Endotoxin and why it is a separate question from purity Started this topic · Analytics › Impurities & related substances · 6 Nov 2025 · 0 likes Endotoxin and why it is a separate question from purity Writing it up because I had to work it out twice and would rather nobody else did. I would like to understand…
-
The nausea timeline across the first four weeks, with a tabulated log — what changed since Replied, post #14 · Practice › Side effects · 28 Oct 2025 · 14 likes Vomiting: when it is expected (first-dose reactions or early titration) and when it is a reason to stop and seek help are different. Occasional vomiting during…
-
Sleep tracking data and its considerable limitations Replied, post #113 · Wellbeing › Sleep · 28 Oct 2025 · 0 likes I read post #111 twice before replying, because I had assumed the opposite. Sleep quality versus quantity: some people report changes to sleep duration; others report…
-
Thyroid function tests during substantial weight change Replied, post #87 · Clinical › Bloodwork · 7 Oct 2025 · 0 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Cagrilintide's dosing interval and the pharmacokinetics behind it Replied, post #70 · Compounds › Cagrilintide & amylin analogues · 4 Oct 2025 · 17 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Coming back to: Where the integrator drew the baseline, and how much it moved the number Replied, post #11 · Analytics › HPLC & UHPLC · 25 Sep 2025 · 15 likes Worth separating two things that post #7 runs together. Column chemistry and particle size: smaller particles (1.7 μm) give better resolution and higher efficiency than…
-
[2026 update] Does dual agonism explain the effect size, or is it dose? Replied, post #3 · Compounds › Tirzepatide · 19 Aug 2025 · 18 likes SURMOUNT-1 reported weight reduction of a magnitude that was the largest for a pharmacological intervention at that time of publication. It also reported a clear dose…
-
A ten-fold dose error caught before injection Replied, post #82 · Devices › Syringes & needles · 14 Aug 2025 · 8 likes post #81 is right about the mechanism and I think understates the practical bit. Sharps disposal: needles and syringes should be disposed in a sharps container (a…
-
A ten-fold dose error caught before injection — one year on Replied, post #9 · Devices › Syringes & needles · 1 Aug 2025 · 7 likes This follows post #6 rather than contradicting it. Dead volume: residual liquid in the hub and needle after withdrawal. Typical residual is 0.01 to 0.02 mL for an…
-
High-resolution MS on aggregates and what it can see Replied, post #34 · Analytics › Mass spectrometry · 1 Aug 2025 · 0 likes Charge states observed: for semaglutide (4113.6 Da) the doubly charged ion appears at m/z ≈ 2057, triply charged at ≈ 1371, quadruply at ≈ 1029. Those are the positions…
-
[2026 update] Citation sweep results: how many references did not say what was claimed Replied, post #41 · Meta › Wiki maintenance · 5 Jul 2025 · 1 like I read post #39 twice before replying, because I had assumed the opposite. Redundancy: if two maintained pages cover largely the same ground, consolidation might…
-
The CagriSema phase 2 paper and what a fixed combination buys Replied, post #63 · Compounds › Cagrilintide & amylin analogues · 2 Jul 2025 · 29 likes Historical amylin analogues: pramlintide was the only long-acting amylin analogue licensed for some time and its poor adherence was a known limitation. A weekly…
-
About the Tirzepatide category Replied, post #3 · Compounds › Tirzepatide · 23 Jun 2025 · 2 likes As a member rather than staff: the most useful thing I did when I started reading this category was to work through the tag pages rather than the topic list. The topic…
-
Repeatability versus intermediate precision Replied, post #16 · Analytics › Method validation · 19 Jun 2025 · 3 likes I read post #14 twice before replying, because I had assumed the opposite. Limits of detection and quantitation: LOD is the lowest concentration that produces a signal…
-
A report I filed that turned out to be wrong, and the correction Replied, post #80 · Sourcing › Vendor reports · 1 Jun 2025 · 27 likes I read post #78 twice before replying, because I had assumed the opposite. Practical note that does not fit anywhere else. Whatever you conclude from this topic, write…
-
A claim built entirely on a subgroup analysis Replied, post #48 · Evidence › Study critique · 22 May 2025 · 29 likes Publication bias: a single published positive trial is weaker evidence than multiple published trials with consistent results. Asking whether there are unpublished…
-
Lean mass preservation: what the evidence supports Replied, post #26 · Outcomes › Body composition · 21 May 2025 · 5 likes Visceral fat: DXA does not distinguish visceral (organ-associated) fat from subcutaneous fat. That distinction might matter but requires different imaging to measure.
-
How Janoshik, Medutest, PeptideMeter and VendorInvestigate differ Replied, post #88 · Sourcing › Independent verification · 13 May 2025 · 16 likes post #87 is right about the mechanism and I think understates the practical bit. How to submit a sample: contact the service directly. They will provide instructions on…
-
Fibre intake when total intake falls, and the constipation link Replied, post #62 · Nutrition & Training › Protein & intake · 3 May 2025 · 27 likes Liquid versus solid: protein in liquid form (shakes) is easier to consume in volume but might not be as satiating as solid food. Using both together can help.
-
Lyophilisation and why the cake looks the way it does Started this topic · Pharmacology › Formulation chemistry · 27 Apr 2025 · 0 likes Posting this under the heading it deserves: Lyophilisation and why the cake looks the way it does Everything below is what sits behind that. I would like to understand…
-
Second pass at: A history of disordered eating: proceeding carefully Replied, post #39 · Wellbeing › Mental health · 24 Apr 2025 · 19 likes Social and relationship impacts: weight change affects how others perceive and interact with a person. Those impacts are real and can be psychologically significant.
-
Second pass at: How to research a compound with no human data without deceiving yourself Replied, post #38 · Compounds › Other compounds · 3 Apr 2025 · 6 likes Sequence verification: for an obscure compound, a report of the amino acid sequence or a mass-spectrometry result confirming the mass is the only verification that…
-
When "no data" is the complete and final answer Replied, post #126 · Compounds › Other compounds · 23 Mar 2025 · 2 likes post #125 is right about the mechanism and I think understates the practical bit. Thank you for the correction. I have edited my earlier post with a note rather than…
-
Retatrutide dose escalation in the published trials Replied, post #38 · Compounds › Retatrutide · 22 Mar 2025 · 1 like Triple agonism: is the effect additive, synergistic, or neither? A phase 2 comparison of tirzepatide (dual) to retatrutide (triple) would answer that question. The…
-
One lot is one lot: when a report becomes a pattern — the long version Replied, post #40 · Sourcing › Vendor reports · 16 Mar 2025 · 9 likes On post #36 — agreed on the reasoning, with one qualification. Blind submission is worth the effort: have someone else relabel the sample so neither you nor the…
-
Charge states for a 4 kDa peptide, worked through Replied, post #93 · Analytics › Mass spectrometry · 13 Mar 2025 · 0 likes Common adducts: sodium adds ≈22, potassium adds ≈38 compared to hydrogen. A [M+Na]+ peak is common and its mass is predictable from the base mass.
-
Charge states for a 4 kDa peptide, worked through Replied, post #78 · Analytics › Mass spectrometry · 11 Mar 2025 · 9 likes Quantitation by MS: most quantitation is done by LC-UV detection at 214 nm, not by MS, because extinction coefficients are better known. MS can quantify if an internal…
-
Biased agonism: a real phenomenon, an over-used explanation Replied, post #75 · Pharmacology › Receptor biology · 11 Mar 2025 · 0 likes Central versus peripheral action: GLP-1 agonism works through both central nervous system effects (appetite) and peripheral effects (gastric motility, insulin). The…
-
What the published dose-response for semaglutide actually looks like above 2.4 mg — a… Replied, post #91 · Compounds › Semaglutide · 7 Mar 2025 · 0 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Revisiting: Semaglutide formulation: what is in the licensed product besides the peptide Replied, post #33 · Compounds › Semaglutide · 23 Dec 2024 · 15 likes On alcohol: the labelling does not contraindicate it, but it raises gastric irritation risk and semaglutide already does that. There is no published interaction study…
-
Coming back to: When to suspect the method rather than the sample Replied, post #72 · Analytics › Method validation · 14 Dec 2024 · 4 likes Accuracy: the method measures what you intend to measure. For purity methods, this is tested by spike-and-recover experiments: add a known amount of impurity to a…
-
Second opinions: how to seek one without burning the first Replied, post #4 · Clinical › Prescriber conversations · 24 Nov 2024 · 17 likes What to bring: copies of relevant lab results, pharmacy records (to confirm doses actually taken), and records of any adverse effects you have experienced with other…
-
Time to steady state after a dose increase Replied, post #49 · Pharmacology › Pharmacokinetics · 3 Nov 2024 · 19 likes Picking up post #46: that is the part I would want checked first. I disagree with the reply above, and I think the disagreement is substantive rather than…
-
US compounding rules and how they changed Replied, post #38 · Regional › North America · 24 Oct 2024 · 25 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
When a red flag was a misunderstanding, and the retraction Replied, post #25 · Sourcing › Red flags · 29 Sep 2024 · 20 likes This follows post #22 rather than contradicting it. Unresponsiveness: a supplier that does not reply to reasonable requests for documentation or clarification is…
-
Follow-up: A site rotation scheme that is easy enough to actually follow Replied, post #32 · Practice › Administration · 16 Sep 2024 · 0 likes A genuinely late dose: the labelling generally says that if the next dose is more than a couple of days away, take it as soon as you notice. If the next dose is close,…
-
Promotion criteria, and the one that stops most nominations Replied, post #59 · Documentation › Doc review · 11 Sep 2024 · 4 likes Review date disputes: if a maintained page's review date is approaching and it has not been updated, post a note so the maintainers notice.
-
Cold packs, phase-change material, and what survives ten days Replied, post #137 · Sourcing › Logistics · 23 Jul 2024 · 26 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…